FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Initial Cannabis Focused Disruptive Biotech with… (LEXX, Jan 2018) | FRC
  1. Home
  2. Latest Reports
  3. Lexaria Bioscience Corp.
  4. Initial Cannabis Focused Disruptive Biotech with Multi-Market Potential
Lexaria Bioscience Corp.

Initial Cannabis Focused Disruptive Biotech with Multi-Market Potential

ByFRC TeamJanuary 12, 2018

Disclosure: Lexaria Bioscience Corp. had paid FRC a fee for research coverage and distribution of reports. This fee creates a potential conflict of interest which readers should consider. See last page for other important disclosures, rating, and risk definitions.

Rating and Key Data

Locked
MetricsValue
Free with an FRC account

Unlock the full LEXX analysis — free account

The rating, fair value and the complete Lexaria Bioscience Corp. profile — not just a price:
ValuationFair value, FRC rating & peer comparablesFundamentalsFinancials, ratios, earnings & dividendsWho's buyingInstitutions, insiders & Congress tradesContextLive quote, chart, news & FRC reports
No credit card. Already have an account?
Preview the LEXX profile

Discussion

Comments reflect the views of individual users, not FRC. Nothing posted in the comments section — by users or otherwise — should be taken as investment advice.

Rating and Key Data

Locked
MetricsValue
Free with an FRC account

Unlock the full LEXX analysis — free account

The rating, fair value and the complete Lexaria Bioscience Corp. profile — not just a price:
ValuationFair value, FRC rating & peer comparablesFundamentalsFinancials, ratios, earnings & dividendsWho's buyingInstitutions, insiders & Congress tradesContextLive quote, chart, news & FRC reports
No credit card. Already have an account?
Preview the LEXX profile